RespireRx Pharmaceuticals Financials

RespireRx Pharmaceuticals Stock Summary

RespireRx Pharmaceuticals competes with Silo Pharma, Pharming Group, Protagenic Therapeutics, Sino Biopharmaceutica, and Eledon Pharmaceuticals. RespireRx Pharmaceuticals Inc. engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. RespireRx Pharmaceuticals Inc. was incorporated in 1987 and is headquartered in Glen Rock, New Jersey. Respirerx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.

RespireRx Pharmaceuticals Key Financial Ratios

RespireRx Pharmaceuticals' financial ratios allow both analysts and investors to convert raw data from RespireRx Pharmaceuticals' financial statements into concise, actionable information that can be used to evaluate the performance of RespireRx Pharmaceuticals over time and compare it to other companies across industries.

RespireRx Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining RespireRx Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare RespireRx Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RespireRx Pharmaceuticals competition to find correlations between indicators driving RespireRx Pharmaceuticals's intrinsic value. More Info.RespireRx Pharmaceuticals is rated third in return on asset category among its peers. It is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value RespireRx Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for RespireRx Pharmaceuticals' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

RespireRx Pharmaceuticals Market Pulse

Along with financial statement analysis, the daily predictive indicators of RespireRx Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of RespireRx Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of RespireRx Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing RespireRx Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build RespireRx Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

If you are still planning to invest in RespireRx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RespireRx Pharmaceuticals' history and understand the potential risks before investing.